2 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow PN M001: new trials by email Literature Review of PN M001 trials Research Report on PN M001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine M-001, Saline - Influenza | Phase 3 | Completed | BiondVax Pharmaceuticals ltd. | 12460 | 2018-08-01 | 2021-10-05 |
| Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV M-001, TIV, Saline - Influenza | Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 37 | 2014-11-01 | 2016-02-23 |
Influenza, Human (2)
BiondVax Pharmaceuticals ltd. (2)
Israel (1) · Poland (1)
Tamar Ben Yedidia, PhD (1) · Tamar Ben-Yedidia, PhD (1)